Karen Lu, MD
Karen Lu, MD
Executive Vice President and Physician-in-Chief
Program: Gynecologic Oncology
Research Program: Health Outcomes & Behavior Program
-
Overview
Gynecological oncology
Associations
- Gynecologic Oncology
- Health Outcomes & Behavior Program
-
Research Interest
Gynecological oncology
-
Publications
- Knisely A, Dai Y, Barlow GL, Lee S, Lawson B, Clark H, Fellman B, Yuan Y, Lu W, Lubo Julio IC, Lazcano RN, Chelvanambi M, Melendez B, Singh B, Singh B, Wani K, Chen J, Yeh CC, Gao J, Barnes S, Shi O, Khan KB, Serrano AG, Gomez-Bolanos LI, Scalise CB, Cheung SK, Dutta P, Velichko S, ElNaggar AC, Liu MC, Wilke RN, How J, Ramondetta LM, Boruta DM, Richardson G, Shafer A, Westin SN, Sims T, Sood AK, Ramirez PT, Lazar AJ, Soliman PT, Lu K, Haymaker CL, Solis Soto LM, Wargo JA, Grisham R, Wucherpfennig KW, Wang L, Jazaeri AA. Surgical and Blood-Based Minimal Residual Disease in Patients with Ovarian Cancer after First-line Therapy: Clinical Outcomes and Translational Opportunities. Clin Cancer Res. 2025 Oct.31(19):4122-4135. Pubmedid: 40748258. Pmcid: PMC12485385.
- Huang M, McCourt C, Powell MA, Lu KH. Amplifying SGO'S voice: The impact of the Society of Gynecologic Oncology (SGO) clinical practice committee publications in Gynecologic Oncology. Gynecol Oncol. 2025 Nov.202:A1-A2. Pubmedid: 41352958.
- Wilke RN, Pennington KP, Gootzen TA, Steenbeek MP, de Hullu JA, Long KC, Blank SV, Swisher EM, Lu KH, Norquist B. Salpingectomy in individuals at high risk for tubo-ovarian cancer: consensus and precaution. Am J Obstet Gynecol. 2025 Nov. Pubmedid: 41183726.
- Ring KL, Mills AM, Howitt BE, Grisham RN, Euscher ED, Kim HS, Klopp AH, Kolin DL, McCluggage WG, Mirkovic J, Park KJ, Aoun E, Awujo C, Son J, Mok SC, Ferri-Borgogno S, Hong DS, Hoang L, Jazaeri AA, How JA, Lu KH. Mesonephric-like adenocarcinoma of the female genital tract: Pathologic diagnosis, clinical outcomes, and novel therapeutics. Gynecol Oncol. 2025 Jun.197:57-65. Pubmedid: 40279981.
- Aoun E, Lawson B, Awujo C, Nebgen D, Soletsky BR, Chisholm GB, Lu KH, Nitecki Wilke R. Oncologic outcomes of incidental serous tubal intraepithelial carcinoma and associated high-grade serous carcinoma in high-risk patients undergoing risk-reducing surgery. Int J Gynecol Cancer. 2025 Jan. Pubmedid: 39496390.
- Gootzen TA, Steenbeek MP, van Gelder MMHJ, van Bommel MHD, Timmer-Bonte JNH, Kets CM, Wilke RN, Swisher EM, Norquist BM, Lu KH, Hermens RPMG, de Hullu JA. Impact of breast cancer history on decision-making for ovarian cancer risk-reducing surgery in the TUBA-WISP-II study. Am J Obstet Gynecol. 2025 Dec.233(6):638.e1-638.e13. Pubmedid: 40532962.
- Faupel-Badger J, Kohaar I, Bahl M, Chan AT, Campbell JD, Ding L, De Marzo AM, Maitra A, Merrick DT, Hawk ET, Wistuba II, Ghobrial IM, Lippman SM, Lu KH, Lawler M, Kay NE, Tlsty TD, Rebbeck TR, Srivastava S. Defining precancer: a grand challenge for the cancer community. Nat Rev Cancer. 2024 Nov.24(11):792-809. Pubmedid: 39354069.
- Bednar EM, Nitecki Wilke R, Jorgensen K, Walsh MT, Nutt S, Lu KH, Nóbrega L, De Souza APSD, da Silva Oliveira G, da Cunha Andrade CEM, Purizaca-Rosillo N, Mora P, López Blanco A, Gallardo-Alvarado LN, Cantú-de León D, Rauh-Hain JA. Feasibility of an environmental scan-based approach to collecting information about factors impacting cancer genetics services in Latin American countries. J Community Genet. 2024 Dec.15(6):681-686. Pubmedid: 39397225. Pmcid: PMC11645378.